Kvantify has expanded its commercial team by appointing Dr. David Siebert as SVP and Global Head of Business Development. This move aligns with the company’s goal to increase the adoption of its hybrid quantum-classical software in life sciences, targeting industrial users before the broader quantum market matures. Siebert, who has a background in scientific and commercial roles in the TechBio sector, will focus on forging partnerships and market expansion, supported by the recent addition of Glenn Jordan as VP of Business Development.
Kvantify is also enhancing its global reach through partnerships in regions like the Middle East, Southeast Asia, and Japan, leveraging established networks to facilitate international growth. Founded in 2022, Kvantify aims to improve molecular discovery, addressing the complexities of integrating quantum technology into practical applications for drug discovery and research.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://itbrief.co.uk/story/kvantify-hires-dr-david-siebert-to-lead-global-sales
